Learning impairment following intracerebral administration of the HIV envelope protein gp120 or a VIP antagonist
Open Access
- 20 January 1992
- journal article
- Published by Elsevier in Brain Research
- Vol. 570 (1-2) , 49-53
- https://doi.org/10.1016/0006-8993(92)90562-n
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- NMDA receptors - their role in long-term potentiationPublished by Elsevier ,2003
- Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the ratPeptides, 1991
- Vasoactive intestinal peptide: A neurotrophic releasing agent and an astroglial mitogenJournal of Neuroscience Research, 1990
- Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptideNature, 1988
- The Brain in AIDS: Central Nervous System HIV-1 Infection and AIDS Dementia ComplexScience, 1988
- Nonneuronal cells mediate neurotrophic action of vasoactive intestinal peptide.The Journal of cell biology, 1987
- CD4 receptor binding peptides that block HIV infectivity cause human monocyte chemotaxisFEBS Letters, 1987
- Shedding and Interspecies Type Sero-reactivity of the Envelope Glycopolypeptide gp120 of the Human Immunodeficiency VirusJournal of General Virology, 1986
- T-lymphocyte T4 molecule behaves as the receptor for human retrovirus LAVNature, 1984
- The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirusNature, 1984